Compare BioNTech SE - ADR (BNTX) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Dolby Laboratories, Inc. — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B). The key difference: BioNTech SE - ADR is far larger — about 4.1× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DLB | |
|---|---|---|
Market Cap | $23.31B | $5.75B |
Sector | Health | Industrials |
52-Week High | $119.34 | $75.62 |
52-Week Low | $83.89 | $48.51 |
Enterprise Value | $6.60B | $5.12B |
Dividend Yield | — | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
